Results 11 to 20 of about 16,901 (313)

Real-world effectiveness of a single dose of mpox vaccine in males

open access: yesNature Medicine, 2023
The recent global outbreak of the monkeypox (mpox) virus in humans was declared a public health emergency by the World Health Organization in July 2022.
Ariel Hammerman, Ronen Arbel
exaly   +2 more sources

Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States

open access: yesNew England Journal of Medicine, 2023
BACKGROUND In the United States, more than 30,000 cases of mpox (formerly known as monkeypox) had occurred as of March 1, 2023, in an outbreak disproportionately affecting transgender persons and gay, bisexual, and other men who have sex with men.
Nicholas P. Deputy   +14 more
exaly   +2 more sources

Mpox-AISM: AI-mediated super monitoring for mpox and like-mpox

open access: yesiScience
Summary: Swift and accurate diagnosis for earlier-stage monkeypox (mpox) patients is crucial to avoiding its spread. However, the similarities between common skin disorders and mpox and the need for professional diagnosis unavoidably impaired the ...
Yubiao Yue   +7 more
doaj   +4 more sources

Mpox in persons with advanced HIV infection: a global case series [PDF]

open access: yesThe Lancet, 2023
Background: People living with HIV have accounted for 38–50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV.
Alemany, A   +3 more
core   +3 more sources

Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023 [PDF]

open access: goldMMWR. Morbidity and mortality weekly report, 2023
As of March 31, 2023, more than 30,000 monkeypox (mpox) cases had been reported in the United States in an outbreak that has disproportionately affected gay, bisexual, and other men who have sex with men (MSM) and transgender persons (1). JYNNEOS vaccine
Alexandra F Dalton   +85 more
semanticscholar   +2 more sources

Mpox epidemiology, barriers to treatment and prevention, and perceived stigma: a cross-sectional study [PDF]

open access: yesBMC Public Health
Background The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may
Angelique E. Boutzoukas   +7 more
doaj   +2 more sources

Establishment of a regional Mpox surveillance network in Central Africa: shared experiences in an endemic region [PDF]

open access: yesGlobal Health Research and Policy
To address the underreporting of mpox cases in endemic regions, a regional surveillance network, known as the Mpox Threat Reduction Network (MPX-TRN), was established between five neighboring countries in Central and West Africa in 2022.
Emmanuel Hasivirwe Vakaniaki   +36 more
doaj   +3 more sources

A survey-based assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands

open access: yesFrontiers in Public Health
BackgroundThe 2022 multicountry mpox outbreaks predominantly affected gay, bisexual and other men who have sex with men (GBMSM) in non-endemic countries, including in the Netherlands.
Philippe C. G. Adam   +11 more
doaj   +3 more sources

Mpox Diagnosis, Behavioral Risk Modification, and Vaccination Uptake among Gay, Bisexual, and Other Men Who Have Sex with Men, United Kingdom, 2022 [PDF]

open access: yesEmerging Infectious Diseases
During the 2022 multicountry mpox outbreak, the United Kingdom identified cases beginning in May. UK cases increased in June, peaked in July, then rapidly declined after September 2022.
Dana Ogaz   +10 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy